Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH) With Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT06123858
What this trial is testing

Non-alcoholic Steatohepatitis Registry Platform Study

Who this might be right for
NASH With Fibrosis
AstraZeneca 1,122
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Not applicableNot Yet RecruitingNCT04925362
What this trial is testing

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
Assistance Publique - Hôpitaux de Paris 900
Testing effectiveness (Phase 2)Study completedNCT02686762
What this trial is testing

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFibrosisLiver Diseases
Conatus Pharmaceuticals Inc. 318
Not applicableStudy completedNCT06940375
What this trial is testing

Incidence of Liver Disease-Related Outcomes in People With HIV

Who this might be right for
MAFLDLiver FibrosisMASH+3 more
Shanghai Public Health Clinical Center 315
Large-scale testing (Phase 3)Study completedNCT00655018
What this trial is testing

Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
InflammationFibrosisInsulin Resistance
Bambino Gesù Hospital and Research Institute 90
Post-approval studies (Phase 4)Study completedNCT00760513
What this trial is testing

Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Hospital Southampton NHS Foundation Trust 103
Not applicableUnknownNCT06098417
What this trial is testing

Biomarkers in the Diagnosis and Prognosis of NAFLD

Who this might be right for
NAFLDObesityLiver Fibrosis+1 more
University of Trieste 500
Not applicableUnknownNCT03842748
What this trial is testing

Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis

Who this might be right for
Non-alcoholic Fatty Liver Disease
Beijing Municipal Administration of Hospitals 300
Not applicableUnknownNCT05120557
What this trial is testing

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Who this might be right for
Liver DiseasesLiver CirrhosisNASH - Nonalcoholic Steatohepatitis+3 more
E-Scopics 1,000
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Not applicableLooking for participantsNCT04190849
What this trial is testing

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty LiverNon-alcoholic Steatohepatitis
Cambridge University Hospitals NHS Foundation Trust 2,000
Post-approval studies (Phase 4)Active Not RecruitingNCT05147090
What this trial is testing

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis bNAFLDCirrhosis+3 more
The University of Hong Kong 106
Large-scale testing (Phase 3)UnknownNCT02530138
What this trial is testing

The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 42
Not applicableStudy completedNCT02231333
What this trial is testing

The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 122
Not applicableLooking for participantsNCT05623150
What this trial is testing

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisAlcohol-related Liver Disease+2 more
Institut National de la Santé Et de la Recherche Médicale, France 710
Testing effectiveness (Phase 2)Study completedNCT02854605
What this trial is testing

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 140
Not applicableLooking for participantsNCT05335603
What this trial is testing

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis

Who this might be right for
Chronic Liver Disease
University of Copenhagen 335
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Testing effectiveness (Phase 2)Study completedNCT00062764
What this trial is testing

Treating Nonalcoholic Steatohepatitis With Pioglitazone

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18
Next Page